Skip to content
No Vape

A quitting trial has a run-in phase: who reached randomization?

Trace pre-randomization participation and selection separately from later follow-up losses or adherence after assignment.

No Vape · Updated

Open book on a cafe table
Illustrative image · Lucille Emi Oh / Unsplash

Find the sequence before the trial groups appear

An abstract may present only the number randomized while a flow diagram starts with more people. Locate enrollment, any run-in phase, randomization and outcome follow-up as separate stages. The label enrolled can vary across reports, so use the authors’ actual definitions. Do not assume that every person appearing before the group split received a randomly assigned intervention.

The original 2016 paper Randomized controlled trials: who fails run-in? explains this pre-randomization phase and possible effects of selection on applicability. It concerns another clinical setting; only the design concept is used here. No treatment, continuation threshold, outcome or instruction from that study is transferred to quitting vaping.

Original research paper — Trials, via PMC: Randomized controlled trials: who fails run-in? (2016)

Keep criteria and actual flow separate

Find the stated purpose, duration and criteria for proceeding, then look for numbers and reasons at each stage. A criterion listed in a protocol is not proof that every exclusion occurred for that reason. Preserve unexplained differences as questions. Avoid labeling people unmotivated or unsuccessful based on a stage they did not complete.

Imagine a fictional support study in which participants first complete a baseline diary and only some proceed under the documented continuation rules. The randomized comparison concerns those who reached that stage. The sketch gives no real study, diary requirement or estimate. Its practical output is a flow showing who entered, who proceeded and what is known about those who did not.

Read the result’s population carefully

Random assignment after a run-in can still address a comparison within the people randomized. It does not turn that selected population into every adult seeking support. Ask whether the earlier phase changed practical demands or characteristics relevant to the claim. A reader can identify that question without deciding that the trial was invalid or that its results must have a particular direction.

This is distinct from excluding people after assignment because they did not adhere, and from losing outcome contact later. The timing changes the question. A report may describe all these stages, but they should not be collapsed into one dropout figure. Keep the flow diagram and analysis population together when reading a headline about how many participants benefited.

Make an applicability note, not a personal entrance test

A useful summary says what the pre-randomization phase involved, which people reached assignment, and what uncertainty remains about applying the comparison more broadly. If details are absent from the summary, seek the full methods. Do not invent requirements or follow another trial’s procedures to test whether you deserve help or would have qualified.

Questions about actual research participation belong with its verified team; care questions belong with appropriate professionals. This page does not recommend entering a study, changing treatment or reproducing a run-in. It makes a hidden selection stage visible so that a reported randomized result stays attached to the population and procedures that actually generated it.

Sources and scope

Sources inform the guidance. The worksheets and examples are No Vape editorial suggestions, not tested treatments.

  1. Original research paper — Trials, via PMC — Randomized controlled trials: who fails run-in? (2016)
  2. No Vape — No Vape — app features and store links

Written with AI assistance and checked against the cited sources. No clinical review is claimed. This guide covers practical planning, not individual medical treatment. How we research and write